Search Clinical Trials
605,319 trials
ID
Status
Phase
Title
Sponsor
NCT07853781
First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy VolunteersNational Institute of Mental Health (NIMH)RecruitingPhase 1
NCT07853781Recruiting
Phase 1
First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy Volun...National Institute of Men...
NCT07853755
Motor Imagery-Assisted Pelvic Floor Muscle Training for Stress Urinary Incontinence in Postmenopausal WomenIstanbul Medipol University HospitalNot Yet RecruitingNot Applicable
NCT07853755Not Yet Recruiting
Not Applicable
Motor Imagery-Assisted Pelvic Floor Muscle Training for Stress Urinary Incontine...Istanbul Medipol Universi...
NCT07855003
Evaluate the Clinical Efficacy and Safety of Non-Compliant PTCA Balloon Dilatation CatheterTEDA International Cardiovascular HospitalCompleted
NCT07855003Completed
—
Evaluate the Clinical Efficacy and Safety of Non-Compliant PTCA Balloon Dilatati...TEDA International Cardio...
NCT07854925
Protective Factors for Well-being in Endometriosis PatientsMaximiliane UhlichNot Yet RecruitingNot Applicable
NCT07854925Not Yet Recruiting
Not Applicable
Protective Factors for Well-being in Endometriosis PatientsMaximiliane Uhlich
NCT07854158
Unilateral Spinal Anesthesia vs Popliteal-Adductor Canal Block for Below-knee AmputationSargodha Medical CollegeNot Yet RecruitingNot Applicable
NCT07854158Not Yet Recruiting
Not Applicable
Unilateral Spinal Anesthesia vs Popliteal-Adductor Canal Block for Below-knee Am...Sargodha Medical College
NCT07856589
Virtual Surgical Planning and Preoperative Plate Bending for Maxillofacial FracturesUniversity of Medicine and Pharmacy at Ho Chi Minh CityNot Yet RecruitingNot Applicable
NCT07856589Not Yet Recruiting
Not Applicable
Virtual Surgical Planning and Preoperative Plate Bending for Maxillofacial Fract...University of Medicine an...
NCT07855731
Assessment of Cervical Range of Motion Restrictions in Infants With Arthrogenic Torticollis - A Feasibility StudyBalgrist University HospitalNot Yet Recruiting
NCT07855731Not Yet Recruiting
—
Assessment of Cervical Range of Motion Restrictions in Infants With Arthrogenic...Balgrist University Hospi...
NCT07853716
REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease CareAvaniaNot Yet RecruitingNot Applicable
NCT07853716Not Yet Recruiting
Not Applicable
REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calc...Avania
NCT07855510
A Clinical Trial of V175 and V175A in Healthy AdultsMerck Sharp & Dohme LLCNot Yet RecruitingPhase 1
NCT07855510Not Yet Recruiting
Phase 1
A Clinical Trial of V175 and V175A in Healthy AdultsMerck Sharp & Dohme LLC
NCT07854652
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic LeukemiaGuangzhou BeBetter Med Co., LtdRecruitingPhase 1
NCT07854652Recruiting
Phase 1
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precurso...Guangzhou BeBetter Med Co...
NCT07856693
Bone and Soft Tissue Healing After Socket Preservation With NOVAMag or Permamem MembranesBotiss Biomaterials GmbHNot Yet RecruitingNot Applicable
NCT07856693Not Yet Recruiting
Not Applicable
Bone and Soft Tissue Healing After Socket Preservation With NOVAMag or Permamem...Botiss Biomaterials GmbH
NCT07853911
Prognostic Value of Stress Hyperglycemia Ratio in Critically Ill PatientsAssiut UniversityNot Yet Recruiting
NCT07853911Not Yet Recruiting
—
Prognostic Value of Stress Hyperglycemia Ratio in Critically Ill PatientsAssiut University
NCT07854600
A Phase II Study of Ivonescimab in Combination With GEMOX as Neoadjuvant and Conversion Therapy for Biliary Tract CancerHaitao Zhao, MDRecruitingPhase 2
NCT07854600Recruiting
Phase 2
A Phase II Study of Ivonescimab in Combination With GEMOX as Neoadjuvant and Con...Haitao Zhao, MD
NCT07856069
Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant MedulloblastomaSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07856069Not Yet Recruiting
Phase 2
Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP...Sun Yat-Sen Memorial Hosp...
NCT07854262
EFFECT OF ESWT ON BREAST-CANCER RELATED LYMPHEDEMAAnkara City Hospital BilkentRecruitingNot Applicable
NCT07854262Recruiting
Not Applicable
EFFECT OF ESWT ON BREAST-CANCER RELATED LYMPHEDEMAAnkara City Hospital Bilk...
NCT07856641
Circadian Variation of Anti-Factor Xa in Hospitalized Trauma PatientsSigma Theta Tau International Grant; Jerold B. Katz Endowment FundRecruiting
NCT07856641Recruiting
—
Circadian Variation of Anti-Factor Xa in Hospitalized Trauma PatientsSigma Theta Tau Internati...
NCT07854548
Wording Approaches to Convey the Strength of Recommendations in Health GuidelinesMcMaster UniversityTerminatedNot Applicable
NCT07854548Terminated
Not Applicable
Wording Approaches to Convey the Strength of Recommendations in Health Guideline...McMaster University
NCT07856511
A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheumatoid ArthritisJiankuan (Suzhou) Biotechnology Company LimitedNot Yet RecruitingPhase 3
NCT07856511Not Yet Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheumat...Jiankuan (Suzhou) Biotech...
NCT07856537
Timing of Complications in the First 24 Hours After Admission to a PostoperativeKanuni Sultan Suleyman Training and Research HospitalRecruiting
NCT07856537Recruiting
—
Timing of Complications in the First 24 Hours After Admission to a PostoperativeKanuni Sultan Suleyman Tr...
NCT07856238
Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract DysfunctionFundación Santa Fe de BogotaNot Yet Recruiting
NCT07856238Not Yet Recruiting
—
Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for...Fundación Santa Fe de Bog...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting6 (30%)
Completed1 (5%)
Terminated1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)